Ignaszewski AP - Search Results

1

Self-reported Morisky score for identifying nonadherence with cardiovascular medications.

Shalansky SJ, Levy AR, Ignaszewski AP. Shalansky SJ, et al. Among authors: ignaszewski ap. Ann Pharmacother. 2004 Sep;38(9):1363-8. doi: 10.1345/aph.1E071. Epub 2004 Jul 6. Ann Pharmacother. 2004. PMID: 15238622

2

The need for revascularization procedures will decrease dramatically in the next decade.

Ignaszewski A. Ignaszewski A. Can J Cardiol. 1998 Apr;14 Suppl A:32A-35A. Can J Cardiol. 1998. PMID: 9594932 Review.

3

The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.

Pamboukian SV, Carere RG, Webb JG, Cook RC, D'yachkova Y, Abel JG, Ignaszewski AP. Pamboukian SV, et al. Among authors: ignaszewski ap. J Heart Lung Transplant. 1999 Apr;18(4):367-71. doi: 10.1016/s1053-2498(98)00070-9. J Heart Lung Transplant. 1999. PMID: 10226902

4

The enigma of recent onset dilated cardiomyopathy: what cause, what consequence, what control?

Chan AW, McManus BM, Ignaszewski AP. Chan AW, et al. Among authors: ignaszewski ap. Can J Cardiol. 2000 May;16(5):641-52. Can J Cardiol. 2000. PMID: 10833543 Review.

5

The evaluation of physician patterns of practice in cardiac patients at two British Columbia tertiary referral hospitals.

Con AH, Ignaszewski A, Gin K, Barr SL. Con AH, et al. Can J Cardiol. 2001 Jun;17(6):695-704. Can J Cardiol. 2001. PMID: 11420581

6

The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease.

Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. Chan SY, et al. J Am Coll Cardiol. 2003 Sep 17;42(6):1037-43. doi: 10.1016/s0735-1097(03)00927-6. J Am Coll Cardiol. 2003. PMID: 13678927

7

The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial.

Lear SA, Ignaszewski A, Linden W, Brozic A, Kiess M, Spinelli JJ, Haydn Pritchard P, Frohlich JJ. Lear SA, et al. Eur Heart J. 2003 Nov;24(21):1920-7. doi: 10.1016/j.ehj.2003.08.015. Eur Heart J. 2003. PMID: 14585250 Clinical Trial.

8

Mycophenolate pharmacokinetics in early period following lung or heart transplantation.

Ensom MH, Partovi N, Decarie D, Ignaszewski AP, Fradet GJ, Levy RD. Ensom MH, et al. Among authors: ignaszewski ap. Ann Pharmacother. 2003 Dec;37(12):1761-7. doi: 10.1345/aph.1D099. Ann Pharmacother. 2003. PMID: 14632536 Clinical Trial.

9

Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes.

Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G. Tildesley HD, et al. Int J Cardiol. 2007 Feb 14;115(3):312-7. doi: 10.1016/j.ijcard.2006.03.014. Epub 2006 Jul 7. Int J Cardiol. 2007. PMID: 16824633

10

Dietary measures and exercise training contribute to improvement of endothelial function and atherosclerosis even in patients given intensive pharmacologic therapy.

Chan SY, Mancini GB, Burns S, Johnson FF, Brozic AP, Kingsbury K, Barr S, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. Chan SY, et al. Among authors: ignaszewski a. J Cardiopulm Rehabil. 2006 Sep-Oct;26(5):288-93. doi: 10.1097/00008483-200609000-00002. J Cardiopulm Rehabil. 2006. PMID: 17003593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results